Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2006 5
2007 4
2008 2
2009 1
2010 2
2013 2
2014 1
2016 2
2017 5
2018 2
2019 3
2020 8
2021 9
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Treatment pathways defined as the sequence of visits to the public health system of patients with cardiomyopathies in Poland in the period 2016-2021.
Mizia-Stec K, Grzybowski J, Cegłowska U, Wiśniewska A, Hałgas K, Wybraniec M, Pachciński O, Stec M, Cieśla D, Gąsior M, Hryniewiecki T, Leszek P. Mizia-Stec K, et al. Among authors: wisniewska a. Kardiol Pol. 2024 Apr 12. doi: 10.33963/v.phj.100178. Online ahead of print. Kardiol Pol. 2024. PMID: 38606740 Free article. No abstract available.
The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder Cancer.
Lasota M, Jankowski D, Wiśniewska A, Sarna M, Kaczor-Kamińska M, Misterka A, Szczepaniak M, Dulińska-Litewka J, Górecki A. Lasota M, et al. Among authors: wisniewska a. Int J Mol Sci. 2023 Dec 23;25(1):269. doi: 10.3390/ijms25010269. Int J Mol Sci. 2023. PMID: 38203437 Free PMC article.
The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age.
Tyczyńska A, Krzempek MK, Cortez AJ, Jurczyszyn A, Godlewska K, Ciepłuch H, Subocz E, Hałka J, Kulikowska de Nałęcz A, Wiśniewska A, Świderska A, Waszczuk-Gajda A, Drozd-Sokołowska J, Guzicka-Kazimierczak R, Wiśniewski K, Porowska A, Knopińska-Posłuszny W, Kłoczko J, Rzepecki P, Woszczyk D, Symonowicz H, Basak GW, Zdziarska B, Jamroziak K, Zaucha JM. Tyczyńska A, et al. Among authors: wisniewska a. Cancers (Basel). 2023 Jul 2;15(13):3469. doi: 10.3390/cancers15133469. Cancers (Basel). 2023. PMID: 37444579 Free PMC article.
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group.
Paszkiewicz-Kozik E, Hus I, Palka M, Dębowska M, Końska A, Kotarska M, Tyczyńska A, Joks M, Twardosz M, Giza A, Wąsik-Szczepanek E, Kalicińska E, Wiśniewska A, Morawska M, Lewicka B, Szymański M, Targoński Ł, Romejko-Jarosińska J, Drozd-Sokołowska J, Subocz E, Swoboda R, Długosz-Danecka M, Lech-Maranda E, Walewski J. Paszkiewicz-Kozik E, et al. Among authors: wisniewska a. Adv Clin Exp Med. 2023 Jan;32(1):131-136. doi: 10.17219/acem/157290. Adv Clin Exp Med. 2023. PMID: 36603138 Free article.
68 results